LATE-BREAKING ABSTRACT: Improving the quality of pathological diagnosis of NSCLC in England

Neal Navani (London, United Kingdom), Neal Navani, Paul Beckett, Susan Harden, Aamir Khakwani, Rosie Dickinson, Richard Hubbard, Ian Woolhouse

Source: International Congress 2016 – Prognostic variables in lung cancer II
Session: Prognostic variables in lung cancer II
Session type: Thematic Poster
Number: 2879
Disease area: Thoracic oncology

Congress or journal article abstractE-poster

Rating: 0
You must login to grade this presentation.

Share or cite this content

Citations should be made in the following way:
Neal Navani (London, United Kingdom), Neal Navani, Paul Beckett, Susan Harden, Aamir Khakwani, Rosie Dickinson, Richard Hubbard, Ian Woolhouse. LATE-BREAKING ABSTRACT: Improving the quality of pathological diagnosis of NSCLC in England. Eur Respir J 2016; 48: Suppl. 60, 2879

You must login to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.

Member's Comments

No comment yet.
You must Login to comment this presentation.


Related content which might interest you:
LATE-BREAKING ABSTRACT: Relationship of compliance to healthcare utilization outcomes and cost of home-telemonitoring for patients with lung cancer
Source: International Congress 2014 – From individual patient interactions to models of care: the nursing perspective
Year: 2014


Improving survival for NSCLC patients in the national lung cancer audit
Source: International Congress 2015 – Quality management in lung cancer
Year: 2015


Lung cancer after lymphoma: Disease characteristics, detection methods and clinical outcome
Source: Annual Congress 2013 –Other thoracic tumours, particular circumstances and rare cases
Year: 2013

Assessment of nutritional status in patients with primary lung cancer
Source: International Congress 2014 – Therapy of thoracic tumours: clinical trials and case series
Year: 2014


Variation in lung cancer diagnosis in England
Source: Annual Congress 2013 –Quality management in thoracic oncology
Year: 2013

Diagnosing lung cancer: Choosing the best for your patient
Source: International Congress 2015 – Developments in lung cancer diagnosis
Year: 2015


Lung cancer in England: Trends in survival over the duration of the national lung cancer audit
Source: Annual Congress 2013 –Epidemiology of respiratory disease
Year: 2013


Improving NLST criteria for lung cancer screening
Source: International Congress 2014 – Improving diagnosis of thoracic tumours
Year: 2014


Lung cancer in women: What are particularities?
Source: International Congress 2014 – The epidemiology of respiratory infections and lung cancer
Year: 2014


Nutrition and lung cancer
Source: International Congress 2016 – Quality management and quality of life in lung cancer
Year: 2016

Lung cancer, has it changed in the last ten years?
Source: International Congress 2015 – Quality management in lung cancer
Year: 2015


Assessment of pain and nutritional status in patients suffering from lung cancer
Source: International Congress 2016 – Kaleidoscope of respiratory nursing
Year: 2016


Component of nursing documentation for monitoring patients suffering from lung cancer
Source: International Congress 2016 – The wide spectrum of respiratory nursing research and practice: across all ages and diseases
Year: 2016


LATE-BREAKING ABSTRACT: Clinical epidemiology of lung cancer in China: a retrospective study of 4205 patients
Source: International Congress 2014 – The epidemiology of respiratory infections and lung cancer
Year: 2014

A feasibility study: Home-telemonitoring for rural lung cancer patients
Source: Annual Congress 2013 –Respiratory nursing care: assessment, interventions and education
Year: 2013


Reducing the rate of emergency presentation in lung cancer
Source: International Congress 2015 – Quality management in lung cancer
Year: 2015

Prognostic factors for survival in lung cancer
Source: Annual Congress 2013 –Prognostic factors and subtyping of lung cancer
Year: 2013

Defining a standard set of patient-centered outcomes for patients with lung cancer
Source: International Congress 2015 – Quality management in lung cancer
Year: 2015

LATE-BREAKING ABSTRACT: Prognostic value of microRNAs expression in stage I-IIIA lung adenocarcinoma (AC)
Source: Annual Congress 2013 –New strategies in epigenomic research to study lung diseases (DNA rearrangements, RNA, methylation, proteosome)
Year: 2013

Analysis of PET-CT use across a UK cancer network: Are we adhering to NICE guidelines?
Source: International Congress 2015 – Quality management in lung cancer
Year: 2015